Mirae Asset Global Investments’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.2K | Buy |
3,794
+542
| +17% | +$9.46K | ﹤0.01% | 1218 |
|
|
2025
Q1 | $40.6K | Buy |
3,252
+13
| +0.4% | +$162 | ﹤0.01% | 1275 |
|
|
2024
Q4 | $34.9K | Sell |
3,239
-267
| -8% | -$2.88K | ﹤0.01% | 1327 |
|
|
2024
Q3 | $50.2K | Buy |
3,506
+613
| +21% | +$8.78K | ﹤0.01% | 1304 |
|
|
2024
Q2 | $23.3K | Buy |
+2,893
| New | +$23.3K | ﹤0.01% | 1361 |
|
|
2024
Q1 | – | Sell |
-16,534
| Closed | -$90.6K | – | 2638 |
|
|
2023
Q4 | $90.6K | Buy |
16,534
+152
| +0.9% | +$833 | ﹤0.01% | 2481 |
|
|
2023
Q3 | $61.9K | Buy |
16,382
+102
| +0.6% | +$386 | ﹤0.01% | 2533 |
|
|
2023
Q2 | $109K | Buy |
+16,280
| New | +$109K | ﹤0.01% | 2483 |
|